Results 221 to 230 of about 9,902,006 (336)
A solar‐powered nanoelectrokinetic filtration system enables high‐flux removal of ultrafine contaminants without relying on nanoscale pores or pressure‐driven membranes, offering a sustainable solution for the off‐grid water purification. Abstract The removal of ultrafine suspended solids from water remains a critical challenge due to the tradeoffs ...
Woonjae Choi +4 more
wiley +1 more source
Delayed Severe Heart Failure Despite Successful Graves' Disease Management. [PDF]
Nakashima H +3 more
europepmc +1 more source
Intensity of Depressive Symptoms and Disorders of Working Memory and Executive Functions in Hyperthyroidism in the Course of Graves’ Disease and Toxic Nodular Goitre [PDF]
Karolina Jabłkowska +3 more
openalex +1 more source
Esketamine and ketamine are widely used for perioperative analgesia and anesthesia. Despite their established roles in analgesia, sedation, and anesthesia, as well as emerging antidepressant, anti‐tumor, and anti‐inflammatory effects, their clinical use is limited due to side effects and addiction potential.
Yinxin Wang +7 more
wiley +1 more source
GRAVES’ DISEASE-ASSOCIATED HEART FAILURE IN YOUNG ADULT MALE
Thomas Fretz +3 more
openalex +1 more source
This study designed a tumor microenvironment‐responsive AIEgen nanoparticle for near‐infrared photoimmunotherapy, which inhibits primary tumors and metastasis by promoting pyroptosis and suppressing aerobic glycolysis. ABSTRACT In advanced osteosarcoma, tumor invasion often prevents complete resection, and immunotherapy is limited by the tumor's ...
Kaiyuan Liu +14 more
wiley +1 more source
Thyrotoxicosis-Associated Hypercoagulability Leading to Concurrent Ischemic Stroke and Pulmonary Embolism in Graves' Disease. [PDF]
Alghanmi AK +3 more
europepmc +1 more source
In vivo optical imaging enhances antibody‐drug conjugate (ADC) optimization by enabling real‐time monitoring of stimulus‐responsive drug behavior. We report n501‐CYMMAF, a ratiometric theranostic with strong target affinity and low‐dose efficacy for ovarian metastasis.
Cheng Li +8 more
wiley +1 more source

